Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

07. September 2021 08:05 ET | Quelle: Guardant Health, Inc.

New Data at IASLC 2021 World Conference on Lung Cancer Demonstrates Advantages of Using the Guardant360® Liquid Biopsy Blood Test for Comprehensive Genomic Profiling in Advanced Lung Cancer

REDWOOD CITY, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) along with leading academic institutions and pharmaceutical companies will present data demonstrating the...
02. September 2021 16:05 ET | Quelle: Guardant Health, Inc.

Guardant Health to Participate in the Morgan Stanley Global Healthcare Conference

REDWOOD CITY, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating virtually in the...
01. September 2020 16:03 ET | Quelle: Guardant Health, Inc.

Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference

REDWOOD CITY, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare...
24. August 2020 08:05 ET | Quelle: Guardant Health, Inc.

Guardant Health Receives FDA Emergency Use Authorization for its Guardant-19 Next Generation Sequencing-Based COVID-19 Test

REDWOOD CITY, Calif., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) announces that the U.S. Food and Drug Administration (FDA) has granted the Guardant-19 test emergency use...
10. August 2020 08:05 ET | Quelle: Guardant Health, Inc.

Guardant Health to Participate in Upcoming August Investor Conferences

REDWOOD CITY, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the following investor virtual conferences. UBS...
07. August 2020 14:25 ET | Quelle: Guardant Health, Inc.

Guardant Health Guardant360® CDx First FDA-Approved Liquid Biopsy for Comprehensive Tumor Mutation Profiling Across All Solid Cancers

REDWOOD CITY, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) announces that the U.S. Food and Drug Administration (FDA) has approved Guardant360® CDx for tumor mutation...
06. August 2020 16:03 ET | Quelle: Guardant Health, Inc.

Guardant Health Reports Second Quarter 2020 Financial Results

Q2 2020 Revenue Increase of 23% Over Prior Year Period REDWOOD CITY, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on...
30. Juli 2020 16:10 ET | Quelle: Guardant Health, Inc.

Guardant Health Announces Collaboration with Radius Health to Develop Liquid Biopsy Companion Diagnostic for Elacestrant

REDWOOD CITY, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced a strategic collaboration with Radius Health, Inc. (Radius, Nasdaq: RDUS) to pursue...
21. Juli 2020 08:05 ET | Quelle: Guardant Health, Inc.

Guardant Health Announces Webcast of Second Quarter Financial Results on August 6, 2020

REDWOOD CITY, Calif., July 21, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the second quarter 2020 after market close on...
08. Juli 2020 08:05 ET | Quelle: Guardant Health, Inc.

Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic

REDWOOD CITY, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced a strategic collaboration with Janssen Biotech, Inc. (Janssen) to pursue regulatory...

Nächste Seite